Open Access
The Maastricht Frailty Screening Tool for Hospitalised Patients ( MFST ‐ HP ) to Identify Non‐Frail Patients
Author(s) -
Warnier Ron M.J.,
Rossum Erik,
Kuijk Sander M.J.,
Mulder Wubbo J.,
Schols Jos M.G.A.,
Kempen Gertrudis I.J.M.
Publication year - 2017
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.13003
Subject(s) - medicine , predictive value , receiver operating characteristic , predictive value of tests , population , area under the curve , emergency medicine , pediatrics , environmental health
Abstract Background The Maastricht frailty screening tool for hospitalised patients ( MFST ‐ HP ) is a frailty screening tool that is fully integrated in the nursing assessment at admission. This study aims to determine the predictive value of the MFST ‐ HP for the health outcomes length of hospital stay, discharge destination, readmission and mortality. Methods Data of 2691 hospitalised patients (70+), admitted between 01‐01‐2013 and 31‐12‐2013, were included in the study. The predictive value of the MFST ‐ HP was analysed by means of receiver operating characteristics curves. Sensitivity, specificity, positive predictive value ( PPV ) and negative predictive value ( NPV ) for different MFST ‐ HP cut‐off scores were examined. Results Mean age of the population was 78.9 years ( SD 6.4) and their average length of stay was 10.2 days ( SD 9.7). Nearly 75.0% of the patients were discharged to their home and around. Approximately 25% of the patients were readmitted within 120 days. Mortality rates were 4.3% and 9.5% (within 30 or 120 days postdischarge, respectively). The area under the curve was moderate and varied from 0.50 to 0.69 for the different outcomes. As a result of high values on negative predictive value (between 73.5% and 96.7%) the MFST ‐ HP is able to rule out a large proportion of non‐frail patients. In this study 84% of the patients had a MFST ‐ HP score of ≥ 6, suggested as most favourable cut off. Conclusions The MFST ‐ HP seems to operate more strongly as a non‐frailty indicator than as a frailty indicator and may in this respect help professionals to decide upon subsequent care. The MFST ‐ HP is able to rule out 84% of the non‐frail population in this study. The remaining 16% need to be assessed by means of a comprehensive geriatric assessment or rapid geriatric assessment, to gain more insight in the level of vulnerability in the frail‐group.